The mechanisms by which T h 1 and T h 2 cells inter-regulate in vivo are still poorly understood. In this study we examined the plasticity of T h 1 cell differentiation and how T h 2 cells may downregulate these responses. We show here that IL-4 affects T h 1 cell responses by two developmentally regulated mechanisms. During the commitment phase of naive CD4 + T cells, IL-4
Introduction
Following stimulation by antigen-presenting cells (APC), CD4 + T cells differentiate into either T h 1 or T h 2 effector cells. Lineage commitment is critically regulated by the cytokines present during the early phase of T cell activation. Thus, IFN-g and IL-12 instruct T h 1 cell development and inhibit T h 2 cell differentiation. The binding of IFN-g to its receptor and subsequent STAT1 activation will induce T-bet gene expression, the master regulator of T h 1 cell differentiation (1±4). The transcription factor T-bet induces IL12Rb2 chain expression, thus allowing for IL-12-dependent STAT4 activation and subsequent T h 1 cell differentiation (2,5±8). In addition, T-bet inhibits, by yet unknown mechanisms, T h 2 cell differentiation (1,7). Conversely, IL-4 instructs T h 2 cell differentiation and inhibits T h 1 cell differentiation through activation of STAT6 and subsequent induction of the expression of GATA-3, the master regulator of T h 2 cell differentiation (9±15). The transcription factor GATA-3 triggers chromatin remodeling at the IL-4/IL-13 locus, and consequently expression of the T h 2 cytokines IL-4, -5 and -13 (13,15±17) . GATA-3 also inhibits T h 1 cell differentiation, likely by direct or indirect inhibition of IFN-g production and IL12Rb2 gene expression (13,15±17) .
Due to these different regulatory circuits T h 1 and T h 2 responses are mutually exclusive in vitro. In vivo, however, T h 1 and T h 2 responses may co-exist, although one response dominates functionally, suggesting a more complex regulation. This is clearly observed in the mouse model of leishmaniasis. Control of Leishmania major infection correlates with development of a T h 1 response, while susceptibility is associated with a dominant T h 2 response. In the early phase of the infection, however, both resistant B10.D2 and susceptible BALB/c mice develop a similar T h 1 and T h 2 response against the parasite L. major (18) . While the T h 2 response extinguishes within 2 weeks of infection in B10.D2 mice, both responses persist in BALB/c mice (18) . More importantly, in BALB/c mice the persistent T h 2 response appears to dominate functionally in vivo, thus preventing parasite clearance by antigen-speci®c T h 1 cells. Functional dominance of T h 2 responses is also observed in some models of autoimmune diabetes. Indeed, in transgenic mice models of autoimmune diabetes as well as in the NOD mouse strain, anti-islet T h 2 response correlates with reduced disease incidence despite the persistence of an isletspeci®c T h 1 response (19±21). These observations raised the possibility that T h 2 cells may regulate T h 1 responses by several different mechanisms, altering the differentiation process as well as the effector phase.
In this study we address this possibility and show that IL-4 affects T h 1 cell responses by two developmentally regulated mechanisms. During the commitment phase of naive CD4 + T cells, IL-4 inhibits T h 1 cell differentiation and induces a reversion of developing T h 1 cells to the T h 2 lineage. In contrast, for effector T h 1 cells IL-4 does not affect the developmental process, but only the transcription of the IFN-g gene. We further show that the difference in IL-4 responsiveness correlates with a loss in effector T h 1 cells of IL-4-dependent up-regulation of GATA-3 expression despite normal activation of STAT6.
Methods

Mice
B10
.BR mice were purchased from Harlan France SARL (Gannat, France). Stat6-de®cient mice were maintained on a B6 background (11) . Six-to 10-week-old mice are used as experimental animals.
Cell puri®cation and in vitro T cell priming
Lymph nodes CD4 + T cells were puri®ed by negative selection using a cocktail of antibodies containing RA36B2 (anti-B220), M1/70.15.11.5HL
(anti-CD11b), 24G2 (anti-FcRII/III), H59.101.2 (anti-CD8) and M5/114.15.2 (pan-anti-MHC class II) followed by incubation with sheep anti-rat IgG and sheep anti-mouse IgG magnetic beads (Dynal, Biotech, Oslo, Norway). After magnetic depletion, the selected population was >90% enriched in CD4 + T cells. When indicated naive CD44 ± CD62L + T cells were puri®ed by FACS sorting using anti-CD44±phycoerythrin and anti-CD62L±FITC (BD PharMingen, La Jolla, CA). For primary stimulation, 5 Q 10 5 CD4 + T cells were incubated with 10 6 irradiated (24 Gy) T celldepleted splenocytes as APC and 1 mg/ml of soluble anti-CD3 (145.2C11) and anti-CD28 (37.51) antibodies. At the indicated time point, cells were washed 3 times, and 5 Q 10 5 CD4 + T cells were re-stimulated with plate-bound anti-CD3 (10 mg/ml) and 1 mg/ml of soluble anti-CD28 in the presence of 50 U/ml recombinant murine IL-2 (Peprotech, Princeton, NJ). To induce T h 1 differentiation, 3.5 ng/ml recombinant murine IL-12 (Peprotech) and 10 mg/ml anti-IL-4 (11B11) were added to the culture. To induce T h 2 differentiation, 10 ng/ml recombinant murine IL-4 (Peprotech) and 10 mg/ml anti-IFN-g (XMG1-2) were added to the culture. For T h 0 conditions, 10 mg/ml of 11B11 and XMG1-2 antibody were added to the cultures. The anti-CD3, anti-CD28, anti-IL-4 and anti-IFN-g antibodies were produced and puri®ed at the Centre d'Immunologie de Marseille-Luminy.
Antibodies and intracellular FACS staining
The anti-CD4±PerCP, anti-IL4±allophycocyanin and anti-IFNg±FITC antibodies were all purchased from BD PharMingen. For intracellular FACS staining, cells were re-stimulated overnight with plate-bound anti-CD3 (10 mg/ml) and 1 mg/ml soluble anti-CD28 in the presence of 50 U/ml of recombinant murine IL-2; 5 mM Monensin (Sigma-Aldrich, St Louis, MO) was added for the last 4 h of stimulation. Quadruple staining were performed as previously described (22) .
Protein extraction and electrophoretic mobility shift assays (EMSA) CD4 + T cells were lysed in buffer A (10 mM HEPES, pH 7.6, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.75 mM spermidine, 0.15 mM spermine, 1 mM DTT and 0.625% NP-40) containing protease inhibitors (0.5 mM PMSF, 2 mg/ml aprotenin, leupeptin, pepstatin A, chymostatin and antipain, 1 mM sodium orthovanadate, 10 mM sodium molybdate, and 1 mM DTT). Cytoplasmic extracts were collected after centrifugation and nuclei were lysed in Nuclear lysis buffer (20 mM HEPES, pH 7.6, 0.4 M NaCl, 1 mM EDTA and 1 mM EGTA) containing protease inhibitors, as described above. For EMSA, 2 mg nuclear proteins were incubated with 5 Q 10 4 32 P-end-labeled double-stranded STAT6 oligonucleotides (3¢-GTATTTCCC-AGAAAAGGAAC-5¢; Santa Cruz Biotechnology, Santa Cruz, CA) in 30 ml binding buffer [50 mM NaCl, 5 mM MgCl 2 , 1 mM DTT, 1 mM EDTA, 5% glycerol and 2 mg of poly(dI±dC)]. For supershift experiments, extracts were pre-incubated for 30 min at room temperature with 2 mg STAT6-speci®c antibody (Santa Cruz Biotechnology) before addition of the labeled probe.
RNA preparation and quantitative RT-PCR
Total RNA was extracted using the High Pure RNA Isolation kit (Roche Diagnostic, Mannheim, Germany) according to the manufacturer's instructions, treated with DNase I (Roche Diagnostic), and reverse transcribed using random primers and Superscript II RT (Life Technology, Grand Island, NY). Real-time PCR was performed on cDNA samples using the SYBR Green system (PE Biosystems, Warrington, UK). Primers used were HPRT sense 5¢-AGC CCT CTG TGT GCT AAG G-3¢, HPRT antisense 5¢-CTG ATA AAA TCT ACA GTC ATA GGA ATG GA-3¢; T-bet sense 5¢-CAA CAA CCC CTT TGC CAA AG-3¢, T-bet antisense 5¢-TCC CCC AAG CAG TTG ACA GT-3¢; GATA-3 sense 5¢-GAG GTG GAC GTA CTT TTT AAC ATC G-3¢, GATA-3 antisense 5¢-GGC ATA CCT GGC TCC CGT-3¢. Cycling conditions were 1 cycle at 50°C for 2 min, 1 cycle at 95°C for 10 min, and 40 cycles each corresponding to 15 s at 95°C and 1 min at 60°C. Analysis used the sequence detection software supplied with the instrument. The relative quantitation value is expressed as 2 ±Dc T , where DC T is the difference between the mean C T value of duplicates of the sample and of the endogenous HPRT control. 
Results
IL-4 inhibits T h 1 responses by two developmentally regulated mechanisms
To examine the plasticity of T h 1 cell differentiation and determine how IL-4 may down-regulate T h 1 cell responses, we analyzed the effect of IL-4 on either the differentiation process or the expression by differentiated T h 1 cells of effector functions. Several studies have shown that stimulation of naive CD4 + T cells under T h 1-polarizing conditions for a period of 48±72 h suf®ces in inducing the differentiation of effector T h 1 cells (23, 24) . Indeed, 24 h stimulation under T h 1-polarizing conditions (IL-12 and anti-IL-4 antibody) of CD4 + T cells isolated from B10.BR mice did not lead to signi®cant differentiation of IFN-g-producing T h 1 cells (Fig. 1A) . By 96 h of primary stimulation >50% of the CD4 + T cells were fully differentiated and produced IFN-g in the absence of IL-4 (Fig. 1A) . Differentiation of CD4 + T cells into IL-4-producing T h 2 cells follows a similar kinetic (Fig. 1A) . Based on these results, we differentiated CD4 + T cells under T h 1-polarizing conditions for 24 or 96 h and re-stimulated them for 48 h in the presence of IL-4 while blocking IFN-g signaling (T h 2-polarizing condition). As control, CD4 + T cells were stimulated twice, with the same kinetics, under either T h 1-or T h 2-polarizing conditions, or T h 1-polarized cultures were re-stimulated under neutral conditions (T h 0, blocking of IL-4 and IFN-g). CD4 + T cells that were activated under T h 1-polarizing conditions for 24 h, then re-stimulated under T h 2-polarizing conditions differentiated exclusively into T h 2 effector cells (Fig. 1A) . Indeed, we detected no IFN-g-producing cells and maximal frequency of IL-4-producing cells in such cultures. Likewise, re-stimulation of 96 h-stimulated T h 1 cells under T h 2-polarizing conditions greatly reduced IFN-g production by these activated T cells (Fig. 1A) . In this case, however, the frequency of IL-4-producing T h 2 cells was only minimally increased (Fig. 1A) . The cytokine production pattern of 24 or 96 h-stimulated T h 1 cells re-stimulated under T h 0 conditions was comparable to that of cultures re-stimulated under T h 1 conditions, further suggesting that the cytokine pro®le of T h 2 re-stimulated cultures clearly results from IL-4 signaling (Fig. 1A) . Finally proliferation of activated CD4 T cells was comparable for the different culture conditions. Thus, the total number of cytokineproducing cells generated in the different re-stimulation conditions was similar (Fig. 1B) . As a consequence, changes in the percentage of cytokine-producing cells were mirrored by similar changes in the number of cytokine-producing cells, further suggesting that IL-4 did not induce the selective death of T h 1 cells, but rather modulated their cytokine production capacity (Fig. 1B) .
To ensure that memory cells may not contribute to the observed phenomena we performed similar experiments with FACS-puri®ed naive CD44 ± CD62L + CD4 + T cells. In this case, too, re-stimulation under T h 2 conditions of 24 h-stimulated T h 1 cells induced a complete reversion to the T h 2 phenotype, while a similar re-stimulation of 96 h-stimulated T h 1 cells only inhibits IFN-g production with no signi®cant increase in IL-4-producing T h 2 cells (Fig. 1C) . Since FACS-sorted naive T cells and total CD4 T cells showed the same response pattern, we used total CD4 T cells in the subsequent experiment.
Collectively, these results suggest that IL-4-mediated regulation of T h 1 responses may proceed by different mechanisms that are developmentally controlled. Thus, during the commitment phase IL-4 blocks T h 1 cell differentiation and redirects the activated T cells towards the T h 2 lineage. In contrast, for differentiated effector T h 1 cells IL-4 does not appear to affect the differentiation process, but only the transcription of the IFN-g gene. The inhibitory effect of IL-4 on IFN-g production should thus be, in the later case, transient and reversible. To test this possibility we activated CD4 + T cells for 96 h under T h 1-polarizing conditions, re-stimulated them for 48 h under T h 2 conditions, then washed out the IL-4 and rested the cells for 48 h in the absence of IL-4 or IL-12. We found that the percentage of IFN-g-producing cells detected in such treated cultures was comparable to that detected in 96 h T h 1 cells (Fig. 1D, cf. b and e) . Thus, as anticipated, the inhibitory effect of IL-4 on IFN-g production was transient.
STAT6 activation is necessary for IL-4-mediated inhibition of T h 1 responses
The contrasted effects of IL-4 on 24 or 96 h T h 1 cells suggested that the signaling pathways activated by IL-4 receptor engagement may be regulated during T h 1 cell differentiation. In agreement, Huang et al. showed that highly polarized T h 1 cells demonstrate a major impairment in IL-4 signaling (25) . Binding of IL-4 to the IL-4 receptor activates pathways involved in regulating proliferation as well as a rapid phosphorylation of the transcription factor STAT6, known to be critical for T h 2 cell differentiation (9±11). We, therefore, determined whether the IL-4 receptor expressed by CD4 + T cells differentiated under T h 1 conditions for 24 or 96 h was capable of activating STAT6. For this experiment we performed EMSA on nuclear extracts to directly analyze STAT6 phosphorylation, subsequent nuclear localization and binding of the dimers to STAT6 sites. In CD4 + T cells differentiated under T h 2 conditions for 24 or 96 h, IL-4 induces the generation of complexes that bind to the STAT6 probe (Fig. 2, lanes 5 and 10) . Binding of these complexes was abolished by pre-incubation of the extracts with a STAT6-speci®c antibody, indicating that these complexes are STAT6 homodimers (Fig. 2, lanes 6 and 11) . IL-4, but not IL-12, induces similar complexes in T h 1 cells differentiated for 24 or 96 h under T h 1-polarizing conditions (Fig. 2, lanes 2, 3, 7 and  8 ). Supershift experiments with STAT6-speci®c antibody con®rmed that these complexes are indeed STAT6 dimers (Fig. 2, lanes 4 and 9) .
Activation of STAT6 following IL-4 binding to the IL-4 receptor therefore proceeds normally in T h 1 cells differentiated for 24 or 96 h under T h 1-polarizing conditions. We further determined using STAT6 ±/± mice whether STAT6 was required for IL-4-mediated inhibition of T h 1 responses in 24 or 96 hstimulated T h 1 cells. As expected, the differentiation of naive CD4 + T cells isolated from STAT6-suf®cient or STAT6-de®cient cells into effector T h 1 cells was comparable (Fig. 3) . As shown above, re-stimulation, under T h 2 conditions, of 24 or 96 hstimulated STAT6-suf®cient T h 1 cells induces a 92 and 64% reduction of IFN-g production, respectively (Fig. 3) . In contrast, the addition of IL-4 during re-stimulation of 24 or 96 h-activated STAT6-de®cient T h 1 cells had only a partial incidence on IFN-g production (Fig. 3) . Indeed, the frequency of IFN-g-producing cells was reduced by 36 and 29.8% when 24 and 96 h T h 1 cells from STAT6-de®cient CD4 + T cells were re-stimulated under T h 2 conditions respectively (Fig. 3) . Partial inhibition of IFN-g production by IL-4 in STAT6-de®cient mice may suggest that IL-4 can repress IFN-g by both STAT6-dependent and STAT6-independent pathways. Alternatively, partial inhibition may re¯ect a proliferative or survival defect of STAT6-de®cient T h 1 cells when deprived of IL-12 (26) . Nonetheless, these results indicate that STAT6 plays an essential role in IL-4-mediated regulation of IFN-g production by both 24 and 96 h T h 1 cells. Furthermore, in agreement with the role of STAT6 in T h 2 cell differentiation, no IL-4-producing T h 2 cells were detected when 24 h-stimulated STAT6-de®cient T h 1 cells were re-stimulated under T h 2 conditions (Fig. 3) .
Altogether, these results show that IL-4 receptor engagement leads to STAT6 activation in both 24 and 96 h-stimulated T h 1 cells, an event that is necessary in both situations for IL-4-mediated inhibition of IFN-g production. Nonetheless, despite a normal activation of STAT6, IL-4 was ineffective at reverting 96 h-stimulated T h 1 cells, suggesting that downstream events of STAT6 activation may be impaired in these differentiated T h 1 cells.
Absence of IL-4-dependent GATA-3 up-regulation in 96 hstimulated T h 1 cells
Activation of STAT6 induces expression of the T h 2-speci®c transcription factor GATA-3 which conditions T h 2 cell devel- opment (12) . We, therefore, examined GATA-3 gene expression by quantitative RT-PCR in the different cultures described above. As previously described, unstimulated T cells express substantial levels of GATA-3 mRNA (14) (Fig. 4a±c) . Expression of GATA-3 is maintained for 24 h, then upregulated in cells stimulated under T h 2 conditions and rapidly extinguished in developing T h 1 cells (Fig. 4a±c) . By 96 h of T h 1 cell differentiation, GATA-3 mRNA expression had increased slightly, reaching a level~30% of that found in naive T cells (Fig. 4b) . Addition of IL-4 during the re-stimulation of 24 hstimulated T h 1 cells, a condition that induces reversion of differentiating T h 1 cells to the T h 2 phenotype, induces a 5.5-fold increase in GATA-3 mRNA expression (Fig. 4a) . This upregulation likely results from IL-4 signaling since it is not observed in 24 h T h 1 cells re-stimulated under T h 0 conditions (Fig. 4a) . In contrast, addition of IL-4 during the re-stimulation of 96 h T h 1 cells, a culture condition that does not permit reversion to the T h 2 lineage, does not signi®cantly modulate GATA-3 expression by this population (Fig. 4b) . In 96 h T h 1 cells, therefore, despite a normal activation, STAT6 is unable to further induce GATA-3. The level of GATA-3 was, however, comparable in 24 and 96 h T h 1 cells re-stimulated under T h 2 conditions, suggesting that the outcome of IL-4 stimulation of 24 and 96 h-stimulated T h 1 cells is not solely determined by the absolute level of GATA-3 expression (Fig. 4a and b) . We, therefore, analyzed expression of the T h 1-speci®c transcription factor T-bet. Stimulation of naive CD4 + T cells under T h 1-polarizing, but not T h 2-polarizing, conditions up-regulated Tbet mRNA expression (Fig. 4d±f) . A slight down-modulation of T-bet mRNA was consistently observed in 96 h-stimulated T h 1 cells (Fig. 4e) . This down-modulation was transient and the Tbet mRNA level increased thereafter (Fig. 4f ). Likewise, a high level of T-bet mRNA expression is observed following restimulation of 24 or 96 h T h 1 cells under T h 1-polarizing conditions ( Fig. 4d and e) . T-bet expression is differently regulated in 24 and 96 h-stimulated T h 1 cells that were restimulated under T h 2 conditions (Fig. 4d and e) . Thus, a signi®cant increase in T-bet mRNA expression levels was only observed upon re-stimulation of 96 h T h 1 cells (Fig. 4d and e) .
Collectively, these results show that the difference in IL-4 responsiveness of 24 and 96 h T h 1 cells correlates with differences in GATA-3 and T-bet regulation. Thus, reversion of 24 h-activated T h 1 cells to the T h 2 lineage following restimulation under T h 2-polarizing conditions correlates with an increased level of GATA-3 expression and a reduced level of T-bet expression. In contrast, in 96 h T h 1 cells re-stimulated under T h 2 conditions, GATA-3 remains low, while T-bet gene expression is up-regulated.
Discussion
In several infectious mice models or models of autoimmune diabetes, both T h 1 and T h 2 responses co-exist, although T h 2 responses dominate functionally (18±21). These observations A critical issue raised by this and a previous study (27) is whether IL-4 directly modulates cytokine production by committed or differentiated T h 1 cells. Since most cultures are likely heterogeneous, as suggested by the limited percentage of cytokine-producing cells, it would be possible that addition of IL-4 to T h 1-stimulated T cells would lead to selective death of T h 1 cells and induce the differentiation of yet uncommitted T cells present in the culture. It is unlikely that this may be the case for 96 h-stimulated T h 1 cells since (i) proliferation was comparable in the different re-stimulation conditions, and (ii) the effect of IL-4 on IFN-g production was, for that population, transient and completely reversible after 48 h culture in the presence of IL-2. Conversely, we cannot conclude from our study that 24 h committed T h 1 cells are reversible. Indeed, in addition to committed T h 1 cells, 24 h T h 1 populations may contain uncommitted cells that could give raise to most T h 2 cells when re-stimulated in the presence of IL-4. A de®nitive answer to the critical issue of whether T h 1 cells are truly reversible awaits the development of reliable markers that may identify committed T h 1 cells. Nonetheless, the 24 h-stimulated T h 1 population shows plasticity, indicating that most T cells from that culture can be directed to the T h 2 lineage when exposed to IL-4. Recent in vivo studies indicate that the initial interaction between antigen-speci®c T cells and antigenpresenting dendritic cells lasts for <24 h (28±31). Plasticity of the 24 h-stimulated T h 1 population would, therefore, suggest that T cell effector function is not set by the initial T cell stimulation, but may be modulated by the cytokine environment the responding T cells meet within the lymph node.
Further biochemical studies show that differentiation into effector cells and the resulting irreversibility of T h 1 cells correlate with alteration of IL-4-dependent regulation of GATA-3 and T-bet. Indeed, despite normal activation, STAT6 is unable to up-regulate GATA-3 and down-regulate T-bet expression in 96 h-stimulated effector T h 1 cells. The absence of IL-4-dependent GATA-3 up-regulation in effector T h 1 cells is likely not due to increased T-bet expression. Indeed, overexpression of T-bet in developing T h 2 cells does not hinder the IL-4-dependent up-regulation of GATA-3 (7). These results suggest that likely STAT6-dependent GATA-3 expression may be repressed in effector T h 1 cells. In agreement, Kurata et al. showed that STAT6-dependent up-regulation of GATA-3 is lost in repeatedly stimulated effector T h 1 cells (12) . How STAT6 regulates GATA-3 expression is still unclear. STAT6 may directly transactivate GATA-3 or allow for the expression of other transcription factors involved in GATA-3 gene transcription. Selective expression, in differentiated effector cells, of inhibitors of these transcription factors may then regulate GATA-3 transcription. Alternatively, epigenetic modi®cation of the GATA-3 locus as a consequence of T h 1 cell differentiation may render the GATA-3 gene inaccessible to transcription factors. Whatever the mechanisms are, the inability of STAT6 to up-regulate GATA-3 likely determines irreversibility of effector T h 1 cells. Indeed, GATA-3 induces chromatin remodeling of the IL-4/IL-13 locus, a necessary step for the expression of the genes present in that locus (17,32±34). In addition, over-expression of GATA-3 inhibits T h 1 cell differentiation (14, 17) . Selective inhibition of STAT6-dependent GATA-3 up-regulation may, therefore, ensure irreversible commitment to the T h 1 lineage. We ®nd, however, that IL-4 is fairly ef®cient at inhibiting IFN-g production by 96 h-stimulated T h 1 cells. This suggests that STAT6 itself or other STAT6-induced factors may negatively regulate transcription of the IFN-g gene. Further dissection of the STAT6-activated pathway will certainly help clarify these different possibilities.
